Mechanistically, LINK-A positively regulated the activation of AKT signaling, and its inhibition overcomes ibrutinib resistance in MCL cells by affecting this pathway (Zhang et al., 2021). The gene discussed is AKT1; the disease is mantle cell lymphoma.